EDURANT is a Oral Tablet, Film Coated in the Human Prescription Drug category. It is labeled and distributed by Janssen Products, Lp. The primary component is Rilpivirine Hydrochloride.
| Product ID | 59676-278_0823bccc-f79a-400b-a8bf-8e0988f7a158 | 
| NDC | 59676-278 | 
| Product Type | Human Prescription Drug | 
| Proprietary Name | EDURANT | 
| Generic Name | Rilpivirine Hydrochloride | 
| Dosage Form | Tablet, Film Coated | 
| Route of Administration | ORAL | 
| Marketing Start Date | 2011-05-20 | 
| Marketing Category | NDA / NDA | 
| Application Number | NDA202022 | 
| Labeler Name | Janssen Products, LP | 
| Substance Name | RILPIVIRINE HYDROCHLORIDE | 
| Active Ingredient Strength | 25 mg/1 | 
| Pharm Classes | Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Non-Nucleoside Analog [EXT], Non-Nucleoside Reverse Transcriptase Inhibitors [MoA] | 
| NDC Exclude Flag | N | 
| Listing Certified Through | 2023-12-31 | 
| Marketing Start Date | 2011-05-20 | 
| NDC Exclude Flag | N | 
| Sample Package? | N | 
| Marketing Category | NDA | 
| Application Number | NDA202022 | 
| Product Type | HUMAN PRESCRIPTION DRUG | 
| Billing Unit | EA | 
| Marketing Start Date | 2011-05-20 | 
| Ingredient | Strength | 
|---|---|
| RILPIVIRINE HYDROCHLORIDE | 25 mg/1 | 
| SPL SET ID: | 03880372-2c68-45c6-a53a-f420c49541d6 | 
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI | |
| UPC Code | 
Mark Image Registration | Serial  | Company  Trademark Application Date  | 
|---|---|
![]() EDURANT  85185858  not registered Dead/Abandoned  | 
        JOHNSON & JOHNSON  2010-11-29  | 
![]() EDURANT  85125575  4013848 Live/Registered  | 
        JOHNSON & JOHNSON  2010-09-09  | 
![]() EDURANT  76647698  not registered Dead/Abandoned  | 
        JOHNSON & JOHNSON  2005-09-29  |